TOS.TO - TSO3 Inc.

Toronto - Toronto Delayed Price. Currency in CAD
0.4100
0.0000 (0.00%)
At close: 3:52PM EDT
Stock chart is not supported by your current browser
Previous Close0.4000
Open0.4100
Bid0.4100 x 0
Ask0.4150 x 0
Day's Range0.4050 - 0.4100
52 Week Range0.2800 - 0.7200
Volume378,202
Avg. Volume476,687
Market Cap38.34M
Beta (3Y Monthly)4.39
PE Ratio (TTM)N/A
EPS (TTM)-0.1330
Earnings DateMay 11, 2018 - May 14, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est0.70
  • CNW Group

    TSO3 Inc. Confirms Purchase Price of CAD $0.43 per Share

    QUÉBEC CITY and MYRTLE BEACH, SC , Sept. 19, 2019 /CNW/ - TSO3 Inc. ("TSO3" or the "Company") (TSX: TOS) confirms that the consideration payable to the shareholders of the Company (the "Shareholders") pursuant to the plan of arrangement (the "Arrangement") involving the Company, Stryker Corporation ("Stryker") and 9402-4874 Québec Inc. (the "Purchaser"), a subsidiary of Stryker, continues to be CAD $0.43 per share. The arrangement agreement (the "Arrangement Agreement") between the Company, Stryker and the Purchaser entered into in connection with the Arrangement provides for an adjustment to the consideration payable to Shareholders based on the amount of transaction costs incurred by the Company in connection with the Arrangement.

  • CNW Group

    TSO3 Inc. reminds shareholders to vote for the arrangement with Stryker

    TSO3 reminds shareholders to vote in favor of the proposed transaction with Stryker, as unanimously recommended by the board of directors of TSO3. ISS and Glass Lewis, two independent leading proxy advisory firms, recommend that TSO3 shareholders vote FOR the proposed transaction. Shareholders who have acquired shares of TSO3 after the record date of August 21, 2019 should know that the voting rights attached to such shares may have already been exercised by the previous shareholder.

  • PR Newswire

    TSO3 Inc. Announces the Filing of its Circular in Connection with the Special Meeting of Shareholders and Reminds Shareholders of the Key Reasons Why the Board Recommends Shareholders to Vote for the Arrangement with Stryker

    QUÉBEC CITY and MYRTLE BEACH, SC, Aug. 23, 2019 /PRNewswire/ - TSO3 Inc. ("TSO3" or the "Company") (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, announces today the filing of its management information circular (the "Circular") and related proxy materials with Canadian securities regulatory authorities in connection with the special meeting of shareholders (the "Special Meeting") to be held at 3:30 p.m. (Eastern Daylight Time) on September 23, 2019 at the offices of Lavery, de Billy, L.L.P. located at 1 Place Ville Marie, Suite 4000, Montréal, Québec, Canada, in accordance with the terms of an interim order of the Québec Superior Court obtained on August 22, 2019. A copy of the Circular may be found under the Company's profile on SEDAR at www.sedar.com and on TSO3's website at https://www.tso3.com/library/.

  • PR Newswire

    TSO3 Reports Second Quarter 2019 Results

    QUEBEC CITY and MYRTLE BEACH, SC, Aug. 12, 2019 /PRNewswire/ - TSO3 Inc. (TOS.TO) ("TSO3" or the "Company"), an innovator in sterilization technology for medical devices in healthcare settings, reports financial results for the second quarter ended June 30, 2019. The Company's net loss was $(4.2) million or $(0.045) per share in the second quarter of 2019, as compared to $(3.4) million or $(0.04) per share in the first quarter of 2019 and $(4.0) million or $(0.04) per share in the year-ago quarter.

  • CNW Group

    TSO3 Inc. Enters into Agreement to be Acquired by Stryker Corporation

    QUÉBEC CITY and MYRTLE BEACH, SC , Aug. 12, 2019 /CNW Telbec/ - TSO3 Inc. ("TSO3" or the "Company") (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, announced today that it has entered into a definitive arrangement agreement (the "Arrangement Agreement") pursuant to which 9402-4874 Québec Inc. (the "Purchaser"), a subsidiary of Stryker Corporation ("Stryker"), will acquire all of the issued and outstanding common shares (the "Shares") of the Company for $0.43  in cash per Share (the "Purchase Price"), subject to adjustment in the event the transaction expenses are greater than currently anticipated. The Company does not currently expect any adjustment to be made to the Purchase Price and in the event such an adjustment would be required, that it would be minimal.

  • Investors Who Bought TSO3 (TSE:TOS) Shares Three Years Ago Are Now Down 88%
    Simply Wall St.

    Investors Who Bought TSO3 (TSE:TOS) Shares Three Years Ago Are Now Down 88%

    Over the last month the TSO3 Inc. (TSE:TOS) has been much stronger than before, rebounding by 36%. But that is meagre...

  • CNW Group

    TSO3 Announces Group Purchasing Agreement with Capstone Health Alliance

    TSO3 Announces Group Purchasing Agreement with Capstone Health Alliance

  • PR Newswire

    TSO3 Announces the Vote Results from its Annual Meeting of the Shareholders

    QUEBEC CITY and MYRTLE BEACH, SC , May 8, 2019 /PRNewswire/ - TSO3 Inc. (TSX: TOS), ("TSO 3 " or the "Company"), an innovator in sterilization technology for medical devices in healthcare ...

  • CNW Group

    TSO3 Reports First Quarter 2019 Results

    TSO3 Reports First Quarter 2019 Results

  • CNW Group

    TSO3 Announces the Dates of its First Quarter 2019 Earnings Conference Call and Annual General Meeting of Shareholders

    QUEBEC CITY , QC and MYRTLE BEACH, SC , April 30, 2019 /CNW Telbec/ - TSO3 Inc. (TOS.TO), ("TSO3" or the "Company"), an innovator in sterilization technology for medical devices in healthcare settings, will hold a conference call to discuss its financial results for the first quarter ended March 31, 2019 and will hold its Annual General Meeting of Shareholders on Tuesday, May 7, 2019 .

  • CNW Group

    TSO3 Announces Changes to the Board of Directors

    MYRTLE BEACH, SC and QUEBEC CITY, April 2, 2019 /CNW Telbec/ - TSO3 Inc. (TOS.TO) ("TSO3" or the "Company"), an innovator in sterilization technology for medical devices in healthcare settings, announced today that it has appointed Sara Elford to the Company's board of directors and further announced the resignation of Douglas Dieter . Ms. Elford enjoyed a long and successful career in Canadian capital markets.

  • CNW Group

    TSO3 Reports Fourth Quarter and Full Year 2018 Results

    TSO3 Reports Fourth Quarter and Full Year 2018 Results

  • CNW Group

    TSO3 Announces Date of Fourth Quarter and Full Year 2018 Earnings Conference Call

    QUEBEC and MYRTLE BEACH , FL, March 21, 2019 /CNW Telbec/ - TSO3 Inc. (TOS.TO) ("TSO3" or the "Company"), an innovator in sterilization technology for medical devices in healthcare settings, will hold a conference call on Thursday, March 28, 2019 , to discuss its financial results for the fourth quarter and full year ended December 31, 2018 . Financial results will be issued in a press release prior to the call. TSO3 President and CEO R.M. (Ric) Rumble and CFO Glen Kayll , will host the conference call, followed by a question and answer period.